AbbVie Reports Second-Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. BBIO
4. NVDA
5. SPY
6. OPCH
7. SKYD
8. GOOGL
9. STZ
10. CHRW

Go back to AbbVie Reports Second-Quarter 2022 Financial Results

AbbVie (ABBV) Shares Fall 6% Following Revenue Miss

July 29, 2022 12:04 PM EDT

AbbVie (NYSE: ABBV) shares tumbled 6% Friday following its earnings report before the open, which beat earnings estimates but missed revenue expectations.

The biopharmaceutical company posted earnings per share of $3.37, $0.03 above expectations of $3.34, with revenue missing the consensus estimate of $14.67 billion, coming in at $14.58 billion. However, revenue did increase 4.5%... More

AbbVie (ABBV) Tops Q2 EPS by 3c, Maintains FY EPS Guidance

July 29, 2022 7:42 AM EDT

AbbVie (NYSE: ABBV) reported Q2 EPS of $3.37, $0.03 better than the analyst estimate of $3.34. Revenue for the quarter came in at $14.58 billion versus the consensus estimate of $14.67 billion.

GUIDANCE:

AbbVie sees FY2022 EPS of $13.78-$13.98, versus the consensus of... More